Merck unit resolves DJ action involving pneumococcal vaccine patents
Clients Merck & Co., Inc.
Jones Day represented Merck Sharp & Dohme Corp. in an action in Delaware district court against Pfizer (through its subsidiaries including Wyeth, LLC) involving several patents on Wyeth’s vaccine technology. The case related to Merck’s new 15-valent pneumococcal conjugate vaccine, known as Vaxneuvance. The matter was dismissed as a result of a worldwide settlement.
Merck Sharp & Dohme Corp. v. Wyeth LLC, No. 1-21-cv-00024 (D. Del.)